Unknown

Dataset Information

Using Artificial Intelligence to Learn Optimal Regimen Plan for Alzheimer's Disease.


ABSTRACT:

Background

Alzheimer's Disease (AD) is a progressive neurological disorder with no specific curative medications. While only a few medications are approved by FDA (i.e., donepezil, galantamine, rivastigmine, and memantine) to relieve symptoms (e.g., cognitive decline), sophisticated clinical skills are crucial to optimize the appropriate regimens given the multiple coexisting comorbidities in this patient population.

Objective

Here, we propose a study to leverage reinforcement learning (RL) to learn the clinicians' decisions for AD patients based on the longitude records from Electronic Health Records (EHR).

Methods

In this study, we withdraw 1,736 patients fulfilling our criteria, from the Alzheimer's Disease Neuroimaging Initiative(ADNI) database. We focused on the

SUBMITTER: Bhattarai K 

PROVIDER: S-EPMC9901063 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature